0001104659-22-072526.txt : 20220617 0001104659-22-072526.hdr.sgml : 20220617 20220617212218 ACCESSION NUMBER: 0001104659-22-072526 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220615 FILED AS OF DATE: 20220617 DATE AS OF CHANGE: 20220617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DeRose Kathleen CENTRAL INDEX KEY: 0001792603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40949 FILM NUMBER: 221025769 MAIL ADDRESS: STREET 1: 230 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10169 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Enfusion, Inc. CENTRAL INDEX KEY: 0001868912 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 125 SOUTH CLARK STREET, SUITE 750 CITY: CHICAGO STATE: IL ZIP: 60603 BUSINESS PHONE: (312) 253-9800 MAIL ADDRESS: STREET 1: 125 SOUTH CLARK STREET, SUITE 750 CITY: CHICAGO STATE: IL ZIP: 60603 4 1 tm2218834-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-06-15 0 0001868912 Enfusion, Inc. ENFN 0001792603 DeRose Kathleen C/O ENFUSION, INC. 125 SOUTH CLARK STREET SUITE 750 CHICAGO IL 60603 1 0 0 0 Class A Common Stock 2022-06-15 4 A 0 12678 0 A 29222 D Consists of restricted stock units ("RSUs") awarded pursuant to the Enfusion, Inc. 2021 Stock Option and Incentive Plan. The restricted stock units will vest in full on the earlier of June 16, 2023, or the date of the 2023 annual meeting of stockholders of the issuer. /s/ Blake Nielsen, as Attorney-in-Fact 2022-06-17